Showing results (2401-2410 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 13, 2010
Phase II study of sunitinib as second-line treatment for advanced gastric cancerYung-Jue Bang, Yoon-Koo Kang, Won K Kang, et al.
Investigational New Drugs|May 8, 2010
Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapyAmélie Lansiaux, Sophie Salingue, Amélie Dewitte, et al.
Investigational New Drugs|May 8, 2010
Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studiesElena Soto, Ron J Keizer, Iñaki F Trocóniz, et al.
Investigational New Drugs|June 5, 2009
Cytotoxic activities of new iron(III) and nickel(II) chelates of some S-methyl-thiosemicarbazones on K562 and ECV304 cellsBelkis Atasever, Bahri Ulküseven, Tülay Bal-Demirci, et al.
Investigational New Drugs|June 6, 2009
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancerStacy Moulder, Navneet Dhillon, Chaan Ng, et al.
Investigational New Drugs|June 10, 2009
Synthesis and identification of a new class of (S)-2,6-diamino-4,5,6,7-tetrahydrobenzo[d]thiazole derivatives as potent antileukemic agentsD S Prasanna, C V Kavitha, B Raghava, et al.
Investigational New Drugs|April 14, 2010
A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumorsHanna K Sanoff, Janine M Davies, Christine Walko, et al.
Investigational New Drugs|May 1, 2009
Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumorsR L Oostendorp, P O Witteveen, B Schwartz, et al.
Investigational New Drugs|May 6, 2009
Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cellsHossam M M Arafa
Investigational New Drugs|May 7, 2009
MMPT: a thiazolidin compound inhibits the growth of lung cancer H1792 cells via Fas-mediated and caspase-dependent apoptosis pathwayYun-feng Zhao, Xiu-lan Li, Yu-xi Sun, et al.
Pageof 372